We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE)

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE) is a biotechnology company specializing in clinical ... read more Featured Products: More products

Download Mobile App





Snibe Demonstrates Cutting-Edge Diagnostic Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025

Snibe (Shenzhen, China) is offering live demonstrations of its cutting-edge diagnostic solutions at Medlab Middle East 2025. More...

Snibe is highlighting the MAGLUMI X Series CLIA analyzers which is designed to meet the different demands of clinical diagnostics, offering advanced automation, precision, and flexibility. With features like high throughput and seamless integration, it makes a lab's workflow smoother and more efficient. The MAGLUMI X series includes the compact and efficient MAGLUMI X3, designed to maintain high performance within a small footprint. The MAGLUMI X8 features an ultra-high-speed module tailored for high-throughput needs, while the MAGLUMI X6 bridges the gap between the X3 and X8. Each model incorporates Snibe’s revolutionary X-Tech, delivering an exceptional performance experience.

Additionally, Snibe is highlighting the SATLARS-T8, a versatile total laboratory automation solution offering extraordinary efficiency, flexibility, compatibility, and intelligence. It is compatible with Snibe’s extremely high-throughput and multi-discipline laboratory solutions, to meet most clinical testing requirements. Also featured at the event is the powerful and highly flexible SATLARS-TCA Total Laboratory Automation system. Compatible with high-throughput analyzers in multiple disciplines, SATLARS-TCA can minimize the need for manual intervention and greatly improve the testing efficiency of labs. Visitors to the Snibe booth can also experience the Biolumi CX8 integrated system that combines two powerful systems--- Biossays C8 and MAGLUMI X8, to achieve simultaneous biochemical and immunological testing. Moreover, it not only has an ultra-high throughput in a minimal footprint, but can also be customized according to your needs, supporting up to 4 instruments connected, and covering the demands of different laboratories.

 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
Respiratory Infections Test
STANDARD Q Adeno Respi Ag Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.